Naltrexone, an opioid receptor antagonist, is commonly used as a relapse prevention medication in alcohol and opiate addiction, but its efficacy and the mechanisms underpinning its clinical usefulness are not well characterized. In the current study, we examined the effects of 50-mg naltrexone compared with placebo on neural network changes associated with substance dependence in 21 alcohol and 36 poly-drug-dependent individuals compared with 36 healthy volunteers. Graph theoretic and network-based statistical analysis of resting-state functional magnetic resonance imaging (MRI) data revealed that alcohol-dependent subjects had reduced functional connectivity of a dispersed network compared with both poly-drug-dependent and healthy subjects...
Context—Medication treatment of alcoholism is presently not particularly robust. Neuroimaging techni...
Background: Naltrexone (NTX) has proven to be effective with alcoholics in treatment, with most cont...
BackgroundDespite known genetic variation across races, studies examining pharmacogenetics of a sing...
Naltrexone, an opioid receptor antagonist, is commonly used as a relapse prevention medication in al...
Naltrexone is an opioid receptor antagonist used in the management of alcohol dependence. Although t...
There is a concerted research effort to investigate brain mechanisms underlying addiction processes ...
Identifying key neural substrates in addiction disorders for targeted drug development remains a maj...
There is a concerted research effort to investigate brain mechanisms underlying addiction processes ...
Identifying key neural substrates in addiction disorders for targeted drug development remains a maj...
AbstractOral naltrexone reduces heavy drinking, but is less consistent as an abstinence promoter, wh...
Research indicates opioid antagonists can reduce alcohol drinking in rodents. However, tests examini...
During the first weeks of abstinence, alcohol craving in patients may increase or “incubate.” We hyp...
Naltrexone, an opioid antagonist, was the second drug approved for treatment of alcohol dependence i...
The endogenous opioid peptide system is hypothesized to be involved in ethanol self-administration a...
Interactions between dopaminergic and opioidergic systems have been implicated in the reinforcing pr...
Context—Medication treatment of alcoholism is presently not particularly robust. Neuroimaging techni...
Background: Naltrexone (NTX) has proven to be effective with alcoholics in treatment, with most cont...
BackgroundDespite known genetic variation across races, studies examining pharmacogenetics of a sing...
Naltrexone, an opioid receptor antagonist, is commonly used as a relapse prevention medication in al...
Naltrexone is an opioid receptor antagonist used in the management of alcohol dependence. Although t...
There is a concerted research effort to investigate brain mechanisms underlying addiction processes ...
Identifying key neural substrates in addiction disorders for targeted drug development remains a maj...
There is a concerted research effort to investigate brain mechanisms underlying addiction processes ...
Identifying key neural substrates in addiction disorders for targeted drug development remains a maj...
AbstractOral naltrexone reduces heavy drinking, but is less consistent as an abstinence promoter, wh...
Research indicates opioid antagonists can reduce alcohol drinking in rodents. However, tests examini...
During the first weeks of abstinence, alcohol craving in patients may increase or “incubate.” We hyp...
Naltrexone, an opioid antagonist, was the second drug approved for treatment of alcohol dependence i...
The endogenous opioid peptide system is hypothesized to be involved in ethanol self-administration a...
Interactions between dopaminergic and opioidergic systems have been implicated in the reinforcing pr...
Context—Medication treatment of alcoholism is presently not particularly robust. Neuroimaging techni...
Background: Naltrexone (NTX) has proven to be effective with alcoholics in treatment, with most cont...
BackgroundDespite known genetic variation across races, studies examining pharmacogenetics of a sing...